In this edition:
BL-B01D1-LUNG-101: Iza-Bren in NSCLC
SOHO-01: sevabertinib in HER2-altered NSCLC
Beamion LUNG-1: zongertinib HER2-altered NSCLC
LOXO-RAS-20001: olomorasib in KRAS G12C-altered NSCLC with brain metastases
REZILIENT2: zipalertinib in NSCLC harbouring ex20ins/other EGFR alterations
FURMO-003: firmonertinib in NSCLC harbouring EGFR ex20ins alterations
PHAROS: 4-year OS results
HARMONi-6: ivonescimab + chemotherapy vs. tislelizumab + chemotherapy in squamous NSCLC
OptiTROP-Lung04: sac-TMT vs. chemotherapy in EGFR-altered, EGFR-TKI-resistant NSCLC
ARTEMIDE-01: rilvegostomig in NSCLC
Please login below to download this issue (PDF)